A Case of Angioedema Associated with Decreased C1 Inhibitor Activity  by Yano, Chizuko et al.
Allergology International Vol 56, No3, 2007 www.jsaweb.jp 309
A Case of Angioedema Associated
with Decreased C1 Inhibitor Activity
Chizuko Yano1, Arihito Ota1 and Hidemi Nakagawa1
ABSTRACT
Background: We report a case of a 31-year-old woman who began to notice swelling of her arms at age 20.
She was once given a diagnosis of cellulitis, but her symptoms spontaneously resolved. The patient had swel-
ling of the left forearm and palm and was referred to our department for evaluation. She had slight pain but no
obvious weight gain.
Case Summary: Antinuclear antibody and other autoantibodies, including anti-ds-DNA antibody, anti-RNP
antibody, anti-Sm antibody, and anti-SS-A antibody were not detected. C1 inhibitor activity was low, C3 was
normal, C4 was low, CH50 was low, and C1q was normal.
Discussion: Based on the presence of the typical clinical features and the positive results on the complement
tests, we diagnosed hereditary angioedema. A decrease in C1 inhibitor activity and an increase in specific pro-
tein concentrations indicated type 1.
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INTRODUCTION
Hereditary angioedema (HAE) is an autosomal domi-
nant disorder characterized by recurrent episodes of
subcutaneous and submucosal edema.1 Triggering
factors in angioedema include surgical procedures
(e.g., tooth extraction), severe heat or cold, strenu-
ous exercise, infections, and in women, menstrual pe-
riods. Increased understanding of the pathophysiol-
ogy of HAE has led to development of specific treat-
ment with intravenous self-administration of human
C1-INH concentrate. However, because of concerns
about viral infection, this is not often used. Patients
are usually given preventive treatment and are care-
fully observed. This report describes a woman with
HAE involving the upper extremities.
CLINICAL SUMMARY
A 31-year-old lactating woman had swelling of the left
forearm and palm and was evaluated by our depart-
ment in October 2005. She began to notice occasional
swelling of her arms at age 20. There was no itching.
This occurred a maximum of 4 or 5 times per year.
She was once given a diagnosis of cellulitis by her
family physician, but during that episode, symptoms
spontaneously resolved in 2―3 days without treat-
ment.
Her left forearm showed some erythema but no
edema. The palm was swollen, with involvement of all
the fingers (Fig. 1).
The patient denied generalized symptoms of dysp-
nea, laryngeal edema, abdominal pain, or diarrhea.
She had no weight gain.
Hereditary angioedema was suspected although
her family had no previous experience of angioe-
dema, and a variety of laboratory tests were per-
formed.
PATHOLOGICAL FINDINGS
Laboratory findings were as follows: WBC 4.9 × 103
μL (Neut 54.3%, Eosino 3.6%, Baso 0.6%, Mono 8.4%,
Lymph 33.1%), RBC 4.58 × 106μL, Hb 14.1 gdL, Ht
40.6%, Plt 267 × 103μL, IgE 146 UmL, IgG 1561
mgdL, IgA 92 mgdL, and IgM 89 mgdL. Bio-
chemical analysis was generally normal. There was
no eosinophilia, and the IgM was within normal lim-
its. Antinuclear antibody tests were normal and com-
plement tests showed a normal C3, decreased C4,
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Fig. 1 The left forearm showing some erythema but no 
edema. The palm was swolen, with involvement of al fin
gers
Fig. 2 Hypothesized mechanism for the initiation of an at
tack of angioedema5
Baseline complement activation
C1 inhibitor AngioedemaActivation FXII
Activated C2
C2 kinin
Bradykinin
Plasmin
Kallikrein
High molecular
weight kininogen
Table 1 Classification of Recurent Angioedema7
1. Hereditary angioedema due to deficiency of C1 inhibitor 
protein and activity (hereditary angioedema type1)
2. Hereditary angioedema due to deficiency of C1 inhibitor 
activity (hereditary angioedema type 2)
3. Hereditary angioedema with normal C1 inhibitor activity 
in women (hereditary angioedema type 3)
4. Acquired angioedema due to increased consumption of 
C1 inhibitor or autoantibody formation (acquired angio-
edema type 1 and 2)
5. Recurent angioedema due to angiotensin-converting 
enzyme inhibitors or angiotensin Ⅱ-receptor antago-
nists
6. Urticaria-related angioedema
7. Idiopathic angioedema
and normal C1q. These findings confirmed a diagno-
sis of hereditary angioedema. A decrease in C1 in-
hibitor activity and an increase in these protein con-
centrations indicated type 1.
A skin biopsy was not performed because the pa-
tient refused to give consent for this procedure. The
patient also declined a skin biopsy or blood testing of
her parents and sister. The patient was observed
without specific treatment. The angioedema resolved
almost completely by the next day. She subsequently
has had only one mild episode of edema and has not
returned for follow-up.
DISCUSSION
Recurrent angioedema can be inherited or acquired
(Table 1).2 HAE is an autosomal dominant disorder
characterized by recurrent episodes of subcutaneous
and submucosal edema.1,2 HAE is due to a deficiency
or dysfunction of complement 1 inhibitor (C1-INH)
protein. In type 1, there is decreased C1-INH protein
and activity. In type 2, there is normal production of
C1-INH but without biochemical activity.2 A new type
3 HAE, a sex-linked disorder occurring only in
women, has also recently been reported.3
About 10% of new cases are due to a gene mutation,
and a negative family history does not rule out HAE.
Pappalardo et al. report a 20% mutation rate of the C1-
INH gene even in the absence of a family history, and
the rate may be as high as 50%.4 The causative gene
is located on the long arm of chromosome 11.
In type 3 HAE, occurring only in women, both C1
inhibitor function and C4 are normal.2,3 The higher
prevalence in women who are pregnant or using oral
contraceptives suggests an estrogen-related effect,
but the causative gene has not been identified.
C1 inhibitor not only inhibits C1, but it also inhibits
many enzymes in the kallikrein-kinin, coagulation,
and fibrinolytic systems (Fig. 2).5 C1 inhibitor defi-
ciency or dysfunction plays a role in the mechanism
of HAE by activation of the complement system. Low
C1 inhibitor leads to uncontrolled activation of factor
XII, which generates kallikrein and plasmin. Kallik-
rein liberates bradykinin from high molecular weight
kininogen, whereas plasmin cleaves off C2 kinin from
activated C2. Activated C2 is continuously produced
during baseline complement activation, which is in-
creased as a result of insufficient control of autoacti-
vation of C1 caused by C1 IHN deficiency. Kinin sys-
tem activation, in association with bradykinin produc-
tion, is an important triggering factor in HAE.
However, if this was the sole mechanism, one
might expect chronic angioedema. But in fact, other
activating factors such as trauma and surgery often
play an important role. Thus, much remains unknown
about the pathophysiology of HAE.
A diagnostic flow sheet is helpful in evaluating an-
gioedema (Fig. 3).6 Family history, age at onset, se-
verity of symptoms, and other underlying disorders
may provide useful information. Screening includes
measurement of C3 and C4 complement levels. If C3
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Fig. 3 Flow sheet for patients with a clinical history of angioedema, revised from6
Clinical history of angioedema
Screening laboratory data: C3, C4
C3→, C4↓C3↓, C4↓ C3→, C4→
Suspicion
of necrotizing 
angitis etc.
(try skin biopsy)
Confirmatory laboratory data: C1q
C1q↓ C1q→
Acquired 
C1 inhibitor
deficiency
angioedema etc.
Suspicion of 
lympho-
proliferative
disorders
C1 INH a.↓
C1 INH p.↓
C1 INH a.↓
C1 INH p.→
C1 INH a.→
C1 INH p.→
or ↑
C1 INH f. ↓
C1 INH a.↓
Type 1 Type 2 Type 3
Hereditary angioedema
a. indicates activity and p. indicates protein.  
IgE-
dependent
angioedema,
idiopathic
angioedema
etc.
is normal and C4 is decreased, C1q should also be
determined. If the latter is normal, HAE should be
suspected.
Triggering factors include surgical procedures
(e.g., tooth extraction, tonsillectomy), infections,
menses, pregnancy, delivery, cold stress, exercise,
and emotional stress. Fatigue after birth and delivery
may have been a precipitating factor in the present
case.
Our patient had no severe episodes of angioedema,
but caution and preventive measures have been rec-
ommended. The management of HAE requires atten-
tion to three areas: treatment of acute episodes of an-
gioedema, long-term prophylaxis, and short-term pro-
phylaxis,7 including tranexamic acid, C1 inhibitors,
and androgen derivatives.
HAE is not common in daily clinical practice, but in
patients with angioedema, measurement of CH50,
C3, and C4 are important screening tests. If C3 is nor-
mal but CH50 and C4 are decreased, HAE should be
strongly suspected.
This was a typical case showing angioedema to the
extremities. It turned out to be type 1 HAE, not the
new type 3, showing low levels of C4 on blood tests.
We believe that exhaustion during nursing may have
caused angioedema. We plan to measure bradykinin
in future cases and observe its correlation with the
clinical course.
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